| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.08 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.08 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.08 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |